Seeking men and women diagnosed with locally-advanced non-small cell lung cancer that can't be treated with surgery for a study of adding an investigational immunotherapy to the standard cancer treatment.
Participants in this study will be randomly assigned to get the investigational immunotherapy drug in addition to chemotherapy and radiation or chemotherapy and radiation alone. All participants will get the investigational immunotherapy drug for one year following their chemotherapy and radiation treatment.
What we're hoping for
We are studying whether adding an investigational immunotherapy drug to the chemotherapy and radiation treatment reduces the risk of cancer spreading for locally advanced non-small cell lung cancer (NSCLC) that can't be treated with surgery.
ClinicalTrials.gov Identifier: NCT04092283